Synthetic selective inhibitors of thrombin.
Okamoto
S
S
Kobe Research Projects on Thrombosis and Haemostasis, Japan.
Hijikata-Okunomiya
A
A
D000595:Amino Acid Sequence; D000818:Animals; D000990:Antithrombin III / Q000494:pharmacology; D000991:Antithrombins / Q000138:chemical synthesis / Q000494:pharmacology* / Q000633:toxicity; D001120:Arginine / Q000031:analogs & derivatives; D002417:Cattle; D003619:Dansyl Compounds / Q000494:pharmacology; D005337:Fibrin / Q000378:metabolism; D005340:Fibrinogen / Q000378:metabolism; D006493:Heparin / Q000494:pharmacology; D006801:Humans; D007231:Infant, Newborn; D007700:Kinetics; D008969:Molecular Sequence Data; D015394:Molecular Structure; D009842:Oligopeptides / Q000138:chemical synthesis / Q000494:pharmacology* / Q000633:toxicity; D010875:Pipecolic Acids / Q000494:pharmacology; D013329:Structure-Activity Relationship; D013379:Substrate Specificity; D013449:Sulfonamides; D013917:Thrombin / Q000037:antagonists & inhibitors* / Q000378:metabolism
D000991:Antithrombins; D003619:Dansyl Compounds; D009842:Oligopeptides; D010875:Pipecolic Acids; D013449:Sulfonamides; D000990:Antithrombin III; D005337:Fibrin; D005340:Fibrinogen; D006493:Heparin; D001120:Arginine; D013917:Thrombin; C031942:argatroban